Saha S K
Cutis. 1985 Jul;36(1):81-2.
A patient with dermal leishmaniasis subsequent to kala-azar was treated with sodium stibogluconate, but the condition did not improve. The patient was then treated with rifampin which has not been used to treat this condition in the past. All clinical features cleared spontaneously by six weeks. No overt disease was noted during the next three months. Rifampin can therefore be used to treat post-kala-azar dermal leishmaniasis when standard procedures are ineffective.
一名患黑热病后继发皮肤利什曼病的患者接受了葡萄糖酸锑钠治疗，但病情未改善。该患者随后接受了利福平治疗，过去未曾使用该药治疗此病症。六周时所有临床症状自行消退。接下来的三个月未发现明显疾病。因此，当标准治疗方法无效时，利福平可用于治疗黑热病后皮肤利什曼病。
